United States 112th Congress Status: Enacted 1 D cosponsors

S 3187 — Food and Drug Administration Safety and Innovation Act

Last action — Became Public Law No: 112-144.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced May 15, 2012. Enacted.

Summary

Food and Drug Administration Safety and Innovation Act

Bill Text

We don't have the full text on file for this bill yet.

Read S 3187 on the official United States source →

Action History

  1. Became Public Law No: 112-144.

  2. Signed by President.

  3. Presented to President.

  4. Message on Senate action sent to the House.

  5. Senate agreed to House amendment to the bill (S. 3187) by Yea-Nay Vote. 92 - 4. Record Vote Number: 168. (consideration: CR S4626)

  6. S.AMDT.2462 SA 2462 fell when SA 2461 withdrawn. (consideration: CR S4626)

  7. S.AMDT.2461 Proposed amendment SA 2461 withdrawn in Senate. (consideration: CR S4626)

  8. Motion by Senator Reid to concur in the House amendment to the bill (S. 3187) with an amendment (SA 2461) withdrawn in Senate by Unanimous Consent. (consideration: CR S4602, S4626; text: CR S4602)

  9. S.AMDT.2462 Considered by Senate. (consideration: CR S4602, S4626)

  10. S.AMDT.2461 Considered by Senate. (consideration: CR S4602, S4626)

  11. Considered by Senate. (consideration: CR S4602-4606, S4610-4627)

  12. S.AMDT.2465 SA 2465 fell when SA 2464 fell.

  13. S.AMDT.2464 SA 2464 fell when SA 2463 fell.

  14. S.AMDT.2463 SA 2463 (instructions to the motion to refer) fell when cloture invoked on the motion to concur in the House amendment to the bill (S.3187).

  15. Motion by Senator Reid to refer to Senate Committee on Health, Education, Labor, and Pensions with instructions to report back forthwith with the following amendment (SA 2463) fell when cloture on the motion to concur in the House amendment to the bill (S. 3187) was invoked in Senate.

  16. Cloture on the motion to concur in the House amendment invoked in Senate by Yea-Nay Vote. 89 - 3. Record Vote Number: 166. (consideration: CR S4449; text: CR S4449)

  17. S.AMDT.2465 Amendment SA 2465 proposed by Senator Reid to Amendment SA 2464. (consideration: CR S4410; text: CR S4410)Of a perfecting nature.

  18. S.AMDT.2464 Amendment SA 2464 proposed by Senator Reid to Amendment SA 2463. (consideration: CR S4410; text: CR S4410)Of a perfecting nature.

  19. S.AMDT.2463 Amendment SA 2463 (the instructions to the motion) proposed by Senator Reid. (consideration: CR S4410; text: CR S4410)To change the enactment date.

  20. Motion by Senator Reid to refer to Senate Committee on Health, Education, Labor, and Pensions with instructions to report back forthwith with the following amendment (SA 2463) made in Senate. (consideration: CR S4410)

  21. S.AMDT.2462 Amendment SA 2462 proposed by Senator Reid to Amendment SA 2461. (consideration: CR S4410; text: CR S4410)Of a perfecting nature.

  22. S.AMDT.2461 Amendment SA 2461 proposed by Senator Reid. (consideration: CR S4410; text: CR S4410)To change the enactment date.

  23. Motion to concur in the House amendment with an amendment (SA 2461) made in Senate. (consideration: CR S4410)

  24. Cloture motion on the motion to concur in the House amendment presented in Senate. (consideration: CR S4410; text: CR S4410)

  25. Motion to concur in the House amendment made in Senate.

  26. Measure laid before Senate by unanimous consent. (consideration: CR S4409-4410)

  27. Message on House action received in Senate and at desk: House amendment to Senate bill.

  28. Motion to reconsider laid on the table Agreed to without objection.

  29. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3825-3861)

  30. DEBATE - The House proceeded with forty minutes of debate on S. 3187.

  31. Considered under suspension of the rules. (consideration: CR H3825-3868)

  32. Mr. Upton moved to suspend the rules and pass the bill, as amended.

  33. Held at the desk.

  34. Received in the House.

  35. Message on Senate action sent to the House.

  36. Passed Senate with amendments by Yea-Nay Vote. 96 - 1. Record Vote Number: 111. (text: CR S3568-3608)

  37. S.AMDT.2127 Motion to table amendment SA 2127 agreed to in Senate by Yea-Nay Vote. 77 - 20. Record Vote Number: 110.

  38. S.AMDT.2130 Proposed amendment SA 2130 withdrawn in Senate. (consideration: CR S3563)

  39. S.AMDT.2109 Amendment SA 2109, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 9 - 88. Record Vote Number: 109.

  40. S.AMDT.2107 Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108.

  41. S.AMDT.2143 Motion to table amendment SA 2143 agreed to in Senate by Yea-Nay Vote. 78 - 15. Record Vote Number: 107.

  42. S.AMDT.2108 Amendment SA 2108, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 46 - 50. Record Vote Number: 106.

  43. S.AMDT.2111 Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.

  44. S.AMDT.2111 Amendment SA 2111 proposed by Senator Bingaman. (consideration: CR S3542-3543, S3547-3548, S3553-3554)To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.

  45. S.AMDT.2146 Amendment SA 2146 as modified agreed to in Senate by Voice Vote. (text as modified: CR S3546)

  46. S.AMDT.2132 Proposed amendment SA 2132 withdrawn in Senate. (consideration: CR S3547)

  47. S.AMDT.2131 Amendment SA 2131 agreed to in Senate by Unanimous Consent.

  48. S.AMDT.2145 Amendment SA 2145 as modified agreed to in Senate by Unanimous Consent.

  49. S.AMDT.2142 Amendment SA 2142 as modified agreed to in Senate by Unanimous Consent. (text as modified: CR S3545-3546)

  50. S.AMDT.2146 Amendment SA 2146 proposed by Senator Harkin for Senator Portman. (consideration: CR S3545-3547, S3548-3550, S3555-3557)To amend the Controlled Substances Act to place synthetic drugs in Schedule I.

  51. S.AMDT.2145 Amendment SA 2145 proposed by Senator Harkin for Senator Portman. (consideration: CR S3555-3557)To facilitate the development of recommendations on interoperability standards to inform and facilitate the exchange of prescription information across State lines.

  52. S.AMDT.2142 Amendment SA 2142 proposed by Senator Harkin for Senator Leahy. (consideration: CR S3545-3547)To modify and limit certain exemptions to the Freedom of Information Act.

  53. S.AMDT.2107 Amendment SA 2107 proposed by Senator McCain. (consideration: CR S3536-3540, 23540, S3541-3542, S3543-3545, S3559-3561, S3562; text: CR S3536-3537)To allow the importation by individuals of safe and affordable drugs from Canada.

  54. S.AMDT.2143 Considered by Senate. (consideration: CR S3536, S3561-3562)

  55. S.AMDT.2132 Considered by Senate. (consideration: CR S3536)

  56. S.AMDT.2131 Considered by Senate. (consideration: CR S3536, S3557-3559)

  57. S.AMDT.2130 Considered by Senate. (consideration: CR S3536)

  58. S.AMDT.2127 Considered by Senate. (consideration: CR S3536, S3550-3553, S3563-3564)

  59. S.AMDT.2109 Considered by Senate. (consideration: CR S3536, S3540-3541, S3543, S3562-3563)

  60. S.AMDT.2108 Considered by Senate. (consideration: CR S3536, S3554-3555)

  61. Considered by Senate. (consideration: CR S3536-3609)

  62. S.AMDT.2126 Amendment SA 2126 agreed to in Senate by Unanimous Consent.

  63. S.AMDT.2151 Amendment SA 2151 as modified agreed to in Senate by Unanimous Consent. (text as modified: CR S3506)

  64. S.AMDT.2129 Amendment SA 2129 agreed to in Senate by Unanimous Consent.

  65. S.AMDT.2121 Amendment SA 2121 agreed to in Senate by Unanimous Consent.

  66. S.AMDT.2141 Amendment SA 2141 agreed to in Senate by Unanimous Consent.

  67. S.AMDT.2125 Amendment SA 2125 agreed to in Senate by Unanimous Consent.

  68. S.AMDT.2126 Amendment SA 2126 proposed by Senator Harkin for Senator Reed. (consideration: CR S3506-3507; text: CR S3506-3507)To make effective the proposed rule of the Food and Drug Administration relating to sunscreen drug products.

  69. S.AMDT.2151 Amendment SA 2151 proposed by Senator Manchin. (consideration: CR S3506-3507)To amend the Controlled Substances Act to make any substance containing hydrocodone as schedule II drug.

  70. S.AMDT.2143 Amendment SA 2143 proposed by Senator Paul. (consideration: CR S3501-3506; text: CR S3501)To amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, to prohibit employees of the Food and Drug Administration from carrying firearms and making arrests without warrants, and to adjust the mens rea of certain prohibited acts under the Federal Food, Drug, and Cosmetic Act to knowing and willful.

  71. S.AMDT.2141 Amendment SA 2141 proposed by Senator Cardin. (consideration: CR S3497-3500, S3500-3501, S3507; text: CR S3497)To require the Commissioner of Food and Drugs to report to Congress on issues with respect to small businesses.

  72. S.AMDT.2125 Amendment SA 2125 proposed by Senator Cardin. (consideration: CR S3497, S3500, S3507; text: CR S3497)To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.

  73. S.AMDT.2108 Amendment SA 2108 proposed by Senator Murkowski. (consideration: CR S3495-3497; text: CR S3495)To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval.

  74. S.AMDT.2130 Amendment SA 2130 proposed by Senator Burr. (consideration: CR S3492-3495; text: CR S3492)To ensure transparency in Food and Drug Administration user fee agreement negotiations.

  75. S.AMDT.2121 Amendment SA 2121 proposed by Senator Grassley. (consideration: CR S3491-3492, S3507; text: CR S3491)To provide employee protections for the Commissioned Corps of the Public Health Service Act.

  76. S.AMDT.2129 Amendment SA 2129 proposed by Senator Grassley. (consideration: CR S3490-3491, S3507; text: CR S3490-3491)To provide deadlines for the issuance of certain regulations and to require a GAO report on the implementation of the clinical trial registration and reporting requirements under the Public Health Service Act.

  77. S.AMDT.2132 Amendment SA 2132 proposed by Senator Coburn. (consideration: CR S3489-3490; text: CR S3489-3490)To provide that a portion of the performance awards of each employee of the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Biologics Evaluation and Research be connected to an evaluation of the employee's contribution to goals under the user fee agreements.

  78. S.AMDT.2131 Amendment SA 2131 proposed by Senator Coburn. (consideration: CR S3488-3489; text: CR S3488-3489)To require an independent assessment of the Food and Drug Administration's review of drug applications.

  79. S.AMDT.2109 Amendment SA 2109 proposed by Senator Sanders. (consideration: CR S3485-3488; text: CR S3485-3486)To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws.

  80. S.AMDT.2127 Amendment SA 2127 proposed by Senator Durbin. (consideration: CR S3482-3485; text: CR S3482-3483)To require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration.

  81. S.AMDT.2122 Amendment SA 2122 agreed to in Senate by Unanimous Consent.

  82. S.AMDT.2122 Amendment SA 2122 proposed by Senator Harkin. (consideration: CR S3487-3482)In the nature of a substitute.

  83. Measure laid before Senate by motion. (consideration: CR S3479-3509)

  84. Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent. (consideration: CR S3479)

  85. Motion to proceed to consideration of measure made in Senate. (consideration: CR S3459-3479)

  86. Motion to proceed to consideration of measure made in Senate. (consideration: CR S3389-3400, S3400-3420)

  87. Cloture motion on the motion to proceed to the measure withdrawn by unanimous consent in Senate. (consideration: CR S3316)

  88. Motion to proceed to consideration of measure made in Senate. (consideration: CR S3295-3307)

  89. Cloture motion on the motion to proceed to the measure presented in Senate. (consideration: CR S3252; text: CR S3252)

  90. Motion to proceed to consideration of measure made in Senate. (consideration: CR S3243-3248, S3252-3271)

  91. Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 400.

  92. Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 3187 do?
Food and Drug Administration Safety and Innovation Act
Who sponsors S 3187?
S 3187 is sponsored by Tom Harkin (D).
What is the current status of S 3187?
This bill has been enacted into law. Introduced May 15, 2012. Enacted.
Where can I track S 3187?
Track S 3187 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3187

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 3187

Last checked for changes about 11 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →